Dr. Ahlman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1120 15th St
Augusta, GA 30912Phone+1 706-721-8623Fax+1 706-721-1459
Education & Training
Medical University of South CarolinaResidency, Nuclear Medicine, 2009 - 2012- Medical University of South Carolina College of MedicineInternship, Transitional Year, 2008 - 2009
Medical College of Georgia at Augusta UniversityClass of 2008
Certifications & Licensure
GA State Medical License 2022 - 2026
MD State Medical License 2012 - 2026
SC State Medical License 2008 - 2012
American Board of Nuclear Medicine Nuclear Medicine
Publications & Presentations
PubMed
- Phase 2 study of alemtuzumab and dose-adjusted EPOCH-R in relapsed or refractory aggressive B-cell lymphomas.Rahul Lakhotia, Christopher Melani, Kieron Dunleavy, Stefania Pittaluga, Sanjal Desai
Leukemia & Lymphoma. 2025-02-03 - Use ofF-fluorodeoxyglucose Positron Emission Tomography to Monitor Disease Activity in Patients With Giant Cell Arteritis on Tocilizumab.Kaitlin A Quinn, Mark A Ahlman, Peter C Grayson
ACR Open Rheumatology. 2025-02-01 - -rearranged B-cell ALL with extramedullary lineage switch to AML following CD19-targeted therapy.Sara K Silbert, Samantha Scanlon, Hao-Wei Wang, Constance M Yuan, Alyssa Doverte
Journal for Immunotherapy of Cancer. 2024-10-26
Abstracts/Posters
- Phase 2 Study of Alemtuzumab Added to Dose-Adjusted EPOCH-R in Relapsed and Refractory Aggressive B-Cell LymphomasMark A. Ahlman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Response-Adapted Therapy in HIV-Associated Diffuse Large B-Cell Lymphoma: Updated Results of a Prospective Phase II Study of Short-Course-EPOCH-RRMark A. Ahlman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
FAPI-PET Can Visualize Changes in Joints of Rheumatoid Arthritis Patients: StudyMarch 17th, 2023- The Challenges of and New Horizons in Takayasu Arteritis ImagingJune 12th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
